15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
"15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A stable prostaglandin endoperoxide analog which serves as a thromboxane mimetic. Its actions include mimicking the hydro-osmotic effect of VASOPRESSIN and activation of TYPE C PHOSPHOLIPASES. (From J Pharmacol Exp Ther 1983;224(1): 108-117; Biochem J 1984;222(1):103-110)
Descriptor ID |
D019796
|
MeSH Number(s) |
D02.737.637.650.500.500 D10.251.355.255.100.637.025.650.500.500 D10.251.355.255.550.025.650.500.500 D23.469.050.175.725.720.720.500.500 D23.469.700.630.500
|
Concept/Terms |
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid- 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid
- 9,11-Dideoxy-11 alpha,9-alpha-epoxymethano-PGF2 alpha
- 9,11-epoxymethano-PGH2
- 9,11 epoxymethano PGH2
- 11 alpha,9 alpha-Epoxymethano PGH2
- 11 alpha,9 alpha Epoxymethano PGH2
- (15S)hydroxy-9alpha,11alpha-(epoxymethano)prosta-5,13-dienoic acid
- (15S)-Hydroxy-11 alpha, 9 alpha-(epoxymethano)prosta-5Z, 13E-dienoic Acid
- 9,11-Dideoxy-11 alpha,9 alpha-epoxymethanoprostaglandin F2 alpha
U-44619- U-44619
- U 44619
- U46619
- U44619
- U-46619
- U 46619
|
Below are MeSH descriptors whose meaning is more general than "15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid".
- Chemicals and Drugs [D]
- Organic Chemicals [D02]
- Peroxides [D02.737]
- Prostaglandin Endoperoxides [D02.737.637]
- Prostaglandins H [D02.737.637.650]
- Prostaglandin H2 [D02.737.637.650.500]
- 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid [D02.737.637.650.500.500]
- Lipids [D10]
- Fatty Acids [D10.251]
- Fatty Acids, Unsaturated [D10.251.355]
- Eicosanoids [D10.251.355.255]
- Arachidonic Acids [D10.251.355.255.100]
- Prostaglandins [D10.251.355.255.100.637]
- Prostaglandin Endoperoxides [D10.251.355.255.100.637.025]
- Prostaglandins H [D10.251.355.255.100.637.025.650]
- Prostaglandin H2 [D10.251.355.255.100.637.025.650.500]
- 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid [D10.251.355.255.100.637.025.650.500.500]
- Prostaglandins [D10.251.355.255.550]
- Prostaglandin Endoperoxides [D10.251.355.255.550.025]
- Prostaglandins H [D10.251.355.255.550.025.650]
- Prostaglandin H2 [D10.251.355.255.550.025.650.500]
- 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid [D10.251.355.255.550.025.650.500.500]
- Biological Factors [D23]
- Inflammation Mediators [D23.469]
- Autacoids [D23.469.050]
- Eicosanoids [D23.469.050.175]
- Prostaglandins [D23.469.050.175.725]
- Prostaglandin Endoperoxides [D23.469.050.175.725.720]
- Prostaglandins H [D23.469.050.175.725.720.720]
- Prostaglandin H2 [D23.469.050.175.725.720.720.500]
- 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid [D23.469.050.175.725.720.720.500.500]
- Prostaglandins, Synthetic [D23.469.700]
- Prostaglandin Endoperoxides, Synthetic [D23.469.700.630]
- 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid [D23.469.700.630.500]
Below are MeSH descriptors whose meaning is more specific than "15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid".
This graph shows the total number of publications written about "15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid" by people in UAMS Profiles by year, and whether "15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2019 | 0 | 1 | 1 | 2005 | 1 | 0 | 1 | 2002 | 0 | 1 | 1 | 2000 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid" by people in Profiles over the past ten years.
-
Zwifelhofer NMJ, Bercovitz RS, Cole R, Yan K, Simpson PM, Moroi A, Newman PJ, Niebler RA, Scott JP, Stuth EAD, Woods RK, Benson DW, Newman DK. Platelet Function Changes during Neonatal Cardiopulmonary Bypass Surgery: Mechanistic Basis and Lack of Correlation with Excessive Bleeding. Thromb Haemost. 2020 Jan; 120(1):94-106.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|